<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="21184" whole_study_id="21184" phs="001223" v="1" p="1" createDate="2016-08-25T15:19:53-05:00" completedByGPADate="2016-08-25T15:38:08-05:00" modDate="2020-01-21T13:21:54-05:00" maxParentChildStudyModDate="2020-01-21T13:21:54-05:00" handle="AR_ProstateCancer" num_participants="57"><StudyInfo accession="phs001223.v1.p1" parentAccession="phs001223.v1.p1"><BioProject id="PRJNA345657" entrez_id="345657" type="bp_admin_access"/><BioProject id="PRJNA345658" entrez_id="345658" type="bp_data_submission"/><StudyNameEntrez>Analysis of AR Gene Rearrangements in Prostate Cancer</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_genome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>dna</StudyType><StudyType>targeted_genome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/><Funding>R01 CA174777</Funding></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="SMDEHM" aid="2" auth="eRA" login="SMDEHM" fname="Scott" lname="Dehm" email="dehm@umn.edu"><Role>PI</Role><Organization>UNIVERSITY OF MINNESOTA</Organization></Person><Person nedid="0010153007" aid="1" auth="cit" login="sathyamn" fname="Neeraja" mname="" lname="Sathyamoorthy" email="sathyamn@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Rendong" lname="Yang" email="yang4414@umn.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014392987" aid="1" auth="cit" login="fingerma" fname="Ian" mname="Michael" lname="Fingerman" email="fingerma@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>Metastatic CRPC samples were obtained from patients who died of CRPC in 2000-2013 and who signed written informed consent for a rapid autopsy performed within 6 h of death, under the aegis of the Prostate Cancer Donor Program at the University of Washington [1].  Localized CRPC samples were obtained by transurethral resection of the prostate (TURP) procedures performed for obstructive uropathy at University of Texas Southwestern Medical Center.  Hormone na&#239;ve prostate cancer tissues from patients with biopsy-confirmed prostate cancer (Gleason Score 6-9) were obtained at the time of radical prostatectomy from the University of Texas Southwestern Medical Center tissue core under UTSW IRB STU 112013-056. We thank the patients and their families who were willing to participate in the Prostate Cancer Donor Program.  We acknowledge Drs. Robert Vessella, Celestia Higano, Bruce Montgomery, Evan Yu, Elahe Mostaghel, Heather Cheng, Paul Lange, Martine Roudier, and Lawrence True and the tissue acquisition teams for their contributions to the University of Washington Prostate Cancer Donor Program.  Additionally, we thank Belinda Nghiem for her technical expertise.  This research was supported by funding from NIH grants R01CA174777, U.S. Department of Defense Prostate Cancer Research Program Transformative Impact Award W81XWH-15-1-0430,  the Pacific Northwest Prostate Cancer SPORE, PO1 NIH grants PO1CA085859; PO1CA163227, and the Richard M. LUCAS Foundation.  
1. Morrissey, C., et al., Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy Series. J Bone Miner Res, 2013. 28(2): p. 333-40.

</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="2172" CGType="cg_class_DS" title="Disease-Specific (Cancer, PUB, MDS)" name="DS-CA-PUB-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Cancer.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>